Related references
Note: Only part of the references are listed.Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa
Craig R. Cohen et al.
AIDS (2010)
Safety, Tolerability, and Pharmacokinetics of SPL7013 Gel (VivaGel®): A Dose Ranging, Phase I Study
John O'Loughlin et al.
SEXUALLY TRANSMITTED DISEASES (2010)
Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials
Janneke H. H. M. van de Wijgert et al.
CONTRACEPTION (2008)
Determining the feasibility of utilizing the microbicide applicator compliance assay for use in clinical trials
Andrea R. Wallace et al.
CONTRACEPTION (2007)
Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study
Jill L. Schwartz et al.
CONTRACEPTION (2006)
Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model
DL Patton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel
IM Malonza et al.
AIDS (2005)
Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses
E Gong et al.
ANTIVIRAL RESEARCH (2005)
In vitro comparison of topical microbicides for prevention of human immunodeficiency virus type 1 transmission
CS Dezzutti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
A randomized Phase I vaginal safety study of three concentrations of C31G vs. Extra Strength Gynol II
CK Mauck et al.
CONTRACEPTION (2004)
Nonoxynol-9 100 mg gel: multi-site safety study from sub-Saharan Africa
IF Hoffman et al.
AIDS (2004)
Poly(sodium 4-styrene sulfonate):: evaluation of a topical microbicide gel against herpes simplex virus type 2 and Chlamydia trachomatis infections in mice
N Bourne et al.
CLINICAL MICROBIOLOGY AND INFECTION (2003)
Safety of single daily use for one week of C31G HEC gel in women
SA Ballagh et al.
CONTRACEPTION (2002)
Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication
YH Gong et al.
ANTIVIRAL RESEARCH (2002)
Recommendations for the clinical development of topical microbicides: an update
C Mauck et al.
AIDS (2001)
Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States
KH Mayer et al.
CLINICAL INFECTIOUS DISEASES (2001)
Share Paper
